|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | |
| A61K 35/28 | |||
| A61K 35/768 | |||
| A61K 39/395 | |||
| A61K 35/30 | |||
| A61K 35/44 | |||
| A61K 38/19 |
| (11) | Patento numeris | 3209382 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15852615.2 |
| Europos patento paraiškos padavimo data | 2015-10-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/057234 |
| Data | 2015-10-23 |
| (87) | Numeris | WO 2016/065330 |
| Data | 2016-04-28 |
| (30) | Numeris | Data | Šalis |
| 201462068557 P | 2014-10-24 | US | |
| 201462073907 P | 2014-10-31 | US |
| (72) |
SZALAY, Aladar, US
MINEV, Boris, US
|
| (73) |
Calidi Biotherapeutics, Inc.,
10210 Campus Point Drive Suite 150, San Diego, CA 92121,
US
|
| (54) | COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER |
| COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER |